Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2014. Start Trial.
Date Value
November 20, 2026 3.424
November 19, 2026 3.798
November 18, 2026 3.782
November 17, 2026 3.605
November 16, 2026 4.909
November 13, 2026 5.524
November 12, 2026 5.414
November 11, 2026 5.833
November 10, 2026 5.816
November 09, 2026 5.714
November 06, 2026 5.370
November 05, 2026 5.244
November 04, 2026 5.562
November 03, 2026 5.462
November 02, 2026 5.504
October 30, 2026 5.879
October 29, 2026 5.727
October 28, 2026 5.714
October 27, 2026 5.572
October 26, 2026 5.410
October 23, 2026 5.428
October 22, 2026 5.476
October 21, 2026 5.782
October 20, 2026 5.79
October 19, 2026 5.933
Date Value
October 16, 2026 6.089
October 15, 2026 6.218
October 14, 2026 6.126
October 13, 2026 6.283
October 12, 2026 6.303
October 09, 2026 6.499
October 08, 2026 6.489
October 07, 2026 6.639
October 06, 2026 7.001
October 05, 2026 7.085
October 02, 2026 7.082
October 01, 2026 7.151
September 30, 2026 7.171
September 29, 2026
September 28, 2026
September 25, 2026
September 24, 2026
September 23, 2026
September 22, 2026
September 21, 2026
September 18, 2026
September 17, 2026
September 16, 2026
September 15, 2026
September 14, 2026

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Omeros Corp. --
Aytu BioPharma, Inc. 0.9159
ANI Pharmaceuticals, Inc. 2.464
Corcept Therapeutics, Inc. 8.345
Veru, Inc. 1.166

Price to Book Value Related Metrics

PS Ratio 4.427
Price 0.4074
Earnings Yield -168.8%
Market Cap 8.014M